益生菌和草药治疗溃疡性结肠炎的热潮

IF 0.4 Q4 PHARMACOLOGY & PHARMACY Asian Journal of Pharmaceutics Pub Date : 2020-06-09 DOI:10.22377/ajp.v14i2.3627
Sankha Bhattacharya
{"title":"益生菌和草药治疗溃疡性结肠炎的热潮","authors":"Sankha Bhattacharya","doi":"10.22377/ajp.v14i2.3627","DOIUrl":null,"url":null,"abstract":"Ulcerative colitis (UC) is an inflammatory chronic disease primarily affecting the colonic mucosa; the extent and severity of colon involvement are variable. In its most limited form, it may be restricted to the distal rectum, while in its most extended form, the entire colon is involved. UC is identified by mucus diarrhea, tenesmus, bowel distension, and anemia. 5-aminosalicylic acid drugs, steroids, and immunosuppressant are used for therapy of UC. The annual occurrence of disease in Asia, America, and Europe was estimated to be 6.3, 19.2, and 24.3/100,000 people years. The main challenges in the management of the disease are drug-related side effects and local targeting. To overcome these challenges, probiotics overcome drug-related adverse side effects and local targeting. On ingestion, the probiotics can result in health beneficial effects. Probiotics are mainly used as gut modulators but are also nowadays explored for their use in UC.","PeriodicalId":8489,"journal":{"name":"Asian Journal of Pharmaceutics","volume":null,"pages":null},"PeriodicalIF":0.4000,"publicationDate":"2020-06-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"4","resultStr":"{\"title\":\"Probiotics and Herbals as a Boom in Treatment of Ulcerative Colitis\",\"authors\":\"Sankha Bhattacharya\",\"doi\":\"10.22377/ajp.v14i2.3627\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Ulcerative colitis (UC) is an inflammatory chronic disease primarily affecting the colonic mucosa; the extent and severity of colon involvement are variable. In its most limited form, it may be restricted to the distal rectum, while in its most extended form, the entire colon is involved. UC is identified by mucus diarrhea, tenesmus, bowel distension, and anemia. 5-aminosalicylic acid drugs, steroids, and immunosuppressant are used for therapy of UC. The annual occurrence of disease in Asia, America, and Europe was estimated to be 6.3, 19.2, and 24.3/100,000 people years. The main challenges in the management of the disease are drug-related side effects and local targeting. To overcome these challenges, probiotics overcome drug-related adverse side effects and local targeting. On ingestion, the probiotics can result in health beneficial effects. Probiotics are mainly used as gut modulators but are also nowadays explored for their use in UC.\",\"PeriodicalId\":8489,\"journal\":{\"name\":\"Asian Journal of Pharmaceutics\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.4000,\"publicationDate\":\"2020-06-09\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"4\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Asian Journal of Pharmaceutics\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.22377/ajp.v14i2.3627\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Asian Journal of Pharmaceutics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.22377/ajp.v14i2.3627","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 4

摘要

溃疡性结肠炎(UC)是一种主要影响结肠粘膜的炎症性慢性疾病;结肠受累的程度和严重程度各不相同。在其最有限的形式中,它可能局限于直肠远端,而在其最延伸的形式中则涉及整个结肠。UC可通过粘液性腹泻、里急后重、肠胀和贫血来确定。5-氨基水杨酸药物、类固醇和免疫抑制剂用于UC的治疗。据估计,亚洲、美洲和欧洲的年发病率分别为6.3、19.2和24.3/10万人年。该疾病管理的主要挑战是与药物相关的副作用和局部靶向。为了克服这些挑战,益生菌克服了与药物相关的不良副作用和局部靶向。摄入益生菌后,可产生有益健康的效果。益生菌主要用作肠道调节剂,但目前也在探索其在UC中的应用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Probiotics and Herbals as a Boom in Treatment of Ulcerative Colitis
Ulcerative colitis (UC) is an inflammatory chronic disease primarily affecting the colonic mucosa; the extent and severity of colon involvement are variable. In its most limited form, it may be restricted to the distal rectum, while in its most extended form, the entire colon is involved. UC is identified by mucus diarrhea, tenesmus, bowel distension, and anemia. 5-aminosalicylic acid drugs, steroids, and immunosuppressant are used for therapy of UC. The annual occurrence of disease in Asia, America, and Europe was estimated to be 6.3, 19.2, and 24.3/100,000 people years. The main challenges in the management of the disease are drug-related side effects and local targeting. To overcome these challenges, probiotics overcome drug-related adverse side effects and local targeting. On ingestion, the probiotics can result in health beneficial effects. Probiotics are mainly used as gut modulators but are also nowadays explored for their use in UC.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Asian Journal of  Pharmaceutics
Asian Journal of Pharmaceutics PHARMACOLOGY & PHARMACY-
自引率
0.00%
发文量
47
期刊介绍: Character of the publications: -Pharmaceutics and Pharmaceutical Technology -Formulation Design and Development -Drug Discovery and Development Interface -Manufacturing Science and Engineering -Pharmacokinetics, Pharmacodynamics, and Drug Metabolism -Clinical Pharmacology, General Medicine and Translational Research -Physical Pharmacy and Biopharmaceutics -Novel Drug delivery system -Biotechnology & Microbiological evaluations -Regulatory Sciences
期刊最新文献
A Design of Experiment-based Approach for the Formulation Development and Evaluation of Repaglinide Transdermal Patch Using Natural Polymers Modification of Human Behavior due to Coronavirus Outbreak: A Brief Study on Current Scenario Formulation and Evaluation of Sustained Release Bilayer Tablets of Losartan Potassium Bioanalytical Method Development and Validation of Empagliflozin by LC–MS/MS Method and Quantitative Estimation of Drug Concentration in Human Plasma Formulation and Evaluation of Antidiabetic Polyherbal Tablets
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1